Alembic Pharma gets EIR for its Karakhadi facility

The company has received EIR from the United States Food and Drug Administration (USFDA) for the inspection carried out at the active pharmaceutical ingredient facility at Karakhadi from May 14-18, 2018, Alembic Pharmaceuticals said in a BSE filing.

Source link

Leave a Reply

Your email address will not be published.